Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand.

A BrockmanShoklo Malaria Research Unit, Mae Sot, Tak, Thailand.

Search for other papers by A Brockman in
Current site
Google Scholar
PubMed
Close
,
R E PaulShoklo Malaria Research Unit, Mae Sot, Tak, Thailand.

Search for other papers by R E Paul in
Current site
Google Scholar
PubMed
Close
,
T J AndersonShoklo Malaria Research Unit, Mae Sot, Tak, Thailand.

Search for other papers by T J Anderson in
Current site
Google Scholar
PubMed
Close
,
I HackfordShoklo Malaria Research Unit, Mae Sot, Tak, Thailand.

Search for other papers by I Hackford in
Current site
Google Scholar
PubMed
Close
,
L PhaiphunShoklo Malaria Research Unit, Mae Sot, Tak, Thailand.

Search for other papers by L Phaiphun in
Current site
Google Scholar
PubMed
Close
,
S LooareesuwanShoklo Malaria Research Unit, Mae Sot, Tak, Thailand.

Search for other papers by S Looareesuwan in
Current site
Google Scholar
PubMed
Close
,
F NostenShoklo Malaria Research Unit, Mae Sot, Tak, Thailand.

Search for other papers by F Nosten in
Current site
Google Scholar
PubMed
Close
, and
K P DayShoklo Malaria Research Unit, Mae Sot, Tak, Thailand.

Search for other papers by K P Day in
Current site
Google Scholar
PubMed
Close
Restricted access

Parasite genotyping by the polymerase chain reaction was used to distinguish recrudescent from newly acquired Plasmodium falciparum infections in a Karen population resident on the northwestern border of Thailand where malaria transmission is low (one infection/person/year). Plasmodium falciparum infections were genotyped for allelic variation in three polymorphic antigen loci, merozoite surface proteins-1 and -2 (MSP-1 and -2) and glutamaterich protein (GLURP), before and after antimalarial drug treatment. Population genotype frequencies were measured to provide the baseline information to calculate the probability of a new infection with a different or the same genotype to the initial pretreatment isolate. Overall, 38% of the infections detected following treatment had an identical genotype before and up to 121 days after treatment. These post-treatment genotypes were considered recrudescent because of the low (< 5%) probability of repeated occurrence by chance in the same patient. This approach allows studies of antimalarial drug treatment to be conducted in areas of low transmission since recrudescences can be distinguished confidently from newly acquired infections.

Save